Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200360775> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W4200360775 endingPage "254" @default.
- W4200360775 startingPage "247" @default.
- W4200360775 abstract "Bexsero® (GlaxoSmithKline) is a four-component Neisseria meningitidis serogroup B vaccine (MenB-4C). It was licensed in the United States in 2015 for use among individuals ages 10-25 years. We aimed to assess the post-licensure safety profile of MenB-4C by examining reports received in the Vaccine Adverse Event Reporting System (VAERS).VAERS is a national passive surveillance system for adverse events (AEs) following immunization that uses the Medical Dictionary for Regulatory Activities to code reported AEs and the Code of Federal Regulations to classify reports by seriousness. In this case series, we analyzed U.S. reports involving MenB-4C received between January 23, 2015 through December 31, 2018. We used Empirical Bayesian data mining to identify MenB-4C/AE combinations reported at least twice as often as expected.VAERS received 1,867 reports following MenB-4C administration, representing 332 reports per million doses distributed. Most reports were for females (59%), with a median age of 17 years (interquartile range: 16-18 years); 40% of reports described simultaneous administration of other vaccines. The majority of reports were classified as non-serious (96%). The most commonly reported AEs were injection site pain (22%), pyrexia (16%), and headache (16%). Data mining identified disproportionate reporting for injected limb mobility decreased secondary to injection site reactions, including extensive swelling of the vaccinated limb and injection site pain.Analysis of passive surveillance data from over 5.6 million doses of MenB-4C distributed in the United States did not reveal new safety concerns. The large majority of reports were classified as non-serious and the reported AEs were generally consistent with the safety experience described in clinical studies and the product's package insert. While our results are reassuring, continued post-marketing surveillance is warranted." @default.
- W4200360775 created "2021-12-31" @default.
- W4200360775 creator A5014457694 @default.
- W4200360775 creator A5025817529 @default.
- W4200360775 creator A5032623164 @default.
- W4200360775 creator A5045248688 @default.
- W4200360775 creator A5045745471 @default.
- W4200360775 creator A5047405171 @default.
- W4200360775 creator A5049754305 @default.
- W4200360775 creator A5078047558 @default.
- W4200360775 creator A5081918699 @default.
- W4200360775 date "2022-01-01" @default.
- W4200360775 modified "2023-10-16" @default.
- W4200360775 title "Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018" @default.
- W4200360775 cites W1794185949 @default.
- W4200360775 cites W1967342248 @default.
- W4200360775 cites W1981809734 @default.
- W4200360775 cites W1983077458 @default.
- W4200360775 cites W2001075268 @default.
- W4200360775 cites W2013392553 @default.
- W4200360775 cites W2036965053 @default.
- W4200360775 cites W2046085703 @default.
- W4200360775 cites W2048507943 @default.
- W4200360775 cites W2056935423 @default.
- W4200360775 cites W2080127475 @default.
- W4200360775 cites W2121993659 @default.
- W4200360775 cites W2135800205 @default.
- W4200360775 cites W2140046908 @default.
- W4200360775 cites W2152757072 @default.
- W4200360775 cites W2153475181 @default.
- W4200360775 cites W2413168313 @default.
- W4200360775 cites W2600877513 @default.
- W4200360775 cites W2730107276 @default.
- W4200360775 cites W2767465229 @default.
- W4200360775 cites W2805179456 @default.
- W4200360775 cites W2810721991 @default.
- W4200360775 cites W2904516406 @default.
- W4200360775 cites W2910917044 @default.
- W4200360775 cites W2914602877 @default.
- W4200360775 cites W2954624981 @default.
- W4200360775 cites W2958334313 @default.
- W4200360775 cites W2989802089 @default.
- W4200360775 cites W3088822708 @default.
- W4200360775 cites W3096848559 @default.
- W4200360775 cites W4233888847 @default.
- W4200360775 cites W4298333804 @default.
- W4200360775 cites W580015659 @default.
- W4200360775 doi "https://doi.org/10.1016/j.vaccine.2021.11.071" @default.
- W4200360775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34887130" @default.
- W4200360775 hasPublicationYear "2022" @default.
- W4200360775 type Work @default.
- W4200360775 citedByCount "5" @default.
- W4200360775 countsByYear W42003607752022 @default.
- W4200360775 countsByYear W42003607752023 @default.
- W4200360775 crossrefType "journal-article" @default.
- W4200360775 hasAuthorship W4200360775A5014457694 @default.
- W4200360775 hasAuthorship W4200360775A5025817529 @default.
- W4200360775 hasAuthorship W4200360775A5032623164 @default.
- W4200360775 hasAuthorship W4200360775A5045248688 @default.
- W4200360775 hasAuthorship W4200360775A5045745471 @default.
- W4200360775 hasAuthorship W4200360775A5047405171 @default.
- W4200360775 hasAuthorship W4200360775A5049754305 @default.
- W4200360775 hasAuthorship W4200360775A5078047558 @default.
- W4200360775 hasAuthorship W4200360775A5081918699 @default.
- W4200360775 hasBestOaLocation W42003607752 @default.
- W4200360775 hasConcept C119060515 @default.
- W4200360775 hasConcept C126322002 @default.
- W4200360775 hasConcept C197934379 @default.
- W4200360775 hasConcept C2777105317 @default.
- W4200360775 hasConcept C71924100 @default.
- W4200360775 hasConceptScore W4200360775C119060515 @default.
- W4200360775 hasConceptScore W4200360775C126322002 @default.
- W4200360775 hasConceptScore W4200360775C197934379 @default.
- W4200360775 hasConceptScore W4200360775C2777105317 @default.
- W4200360775 hasConceptScore W4200360775C71924100 @default.
- W4200360775 hasIssue "2" @default.
- W4200360775 hasLocation W42003607751 @default.
- W4200360775 hasLocation W42003607752 @default.
- W4200360775 hasLocation W42003607753 @default.
- W4200360775 hasOpenAccess W4200360775 @default.
- W4200360775 hasPrimaryLocation W42003607751 @default.
- W4200360775 hasRelatedWork W1669499790 @default.
- W4200360775 hasRelatedWork W1967736925 @default.
- W4200360775 hasRelatedWork W2342267228 @default.
- W4200360775 hasRelatedWork W2918034594 @default.
- W4200360775 hasRelatedWork W2982021612 @default.
- W4200360775 hasRelatedWork W3011938841 @default.
- W4200360775 hasRelatedWork W4280493563 @default.
- W4200360775 hasRelatedWork W4281861147 @default.
- W4200360775 hasRelatedWork W4282838629 @default.
- W4200360775 hasRelatedWork W4377565853 @default.
- W4200360775 hasVolume "40" @default.
- W4200360775 isParatext "false" @default.
- W4200360775 isRetracted "false" @default.
- W4200360775 workType "article" @default.